Fortis Healthcare cash flow

Latest FY26

Cash from operations: ₹1,602cr+12.5% on FY25
Capital spending: ₹946cr+11.6% on FY25
Free cash flow: ₹656cr+13.7% on FY25
Cash from financing: ₹164cr−₹714 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	449	386	343	316
	—	−32.9	89.3	0.0	−73.6
	—	314	184	131	129
	—	−39.4	−59.8	0.0	−23.8
	—	0.0	0.0	0.0	0.0
	—	−0.2	0.8	0.0	−15.5
	—	30.7	51.8	0.0	14.8
	—	−2.6	−3.4	0.0	0.0
	—	0.0	0.0	−16.0	−17.6
	—	−15.7	−8.6	13.9	−2.0
	—	−281	−220	−87.9	−123
	—	−13.2	−4.6	0.0	−10.5
	—	−96.6	95.0	0.0	−2.1
	—	−6.9	−6.7	−22.9	9.3
	—	40.7	−75.4	0.0	−24.3
	—	0.0	0.3	0.0	0.0
	—	113	104	51.9	104
	—	36.4	0.0	0.0	0.0
	—	−37.7	−1,661	0.0	17.4
	—	−11.6	1,660	0.0	−0.0
	—	21.7	4.1	64.6	11.4
	—	4.2	3.3	0.0	−11.8
	—	48.5	−1.4	0.0	7.2
Cash from operating activities
	1,361	1,350	996	848	792
	—	522	538	477	305
	—	1,871	1,534	1,326	1,096
	—	0.0	0.0	29.9	0.0
	—	0.4	0.0	−33.5	0.0
	—	270	110	222	274
	—	1,602	1,424	1,100	822
Cash from investing activities
	—	946	847	942	447
	—	17.2	40.1	14.5	22.3
	—	0.0	0.0	111	0.0
	—	0.0	0.0	0.8	0.0
	—	870	0.0	0.0	0.0
	—	0.0	0.0	150	0.0
	—	0.0	0.0	47.7	0.0
	—	0.0	27.9	0.0	12.5
	—	0.0	0.9	0.0	0.0
	—	5.5	0.0	4.9	2.8
	—	39.5	59.7	29.8	25.6
	—	215	−5.2	15.6	35.4
	—	−1,538	−779	−886	−374
Cash from financing activities
	—	0.0	1,778	0.0	0.0
	—	0.0	1,550	0.0	0.0
	—	1,271	11.3	612	240
	—	668	198	426	522
	—	58.7	52.0	0.0	43.8
	—	—	—	55.9	0.0
	—	303	138	130	130
	—	77.7	109	86.0	16.0
	—	164	−714	−86.5	−471
	—	227	−69.3	127	−22.7
	—	1.3	−0.5	−2.8	1.2
	—	228	−69.8	125	−21.4
	—	328	—	170	45.1
Reference items
	2,131	2,085	1,588	1,268	1,101
	22.4%	22.8%	20.4%	18.4%	17.5%
	656	656	577	158	375
	—	751	2,056	−39.8	—
	₹8.69	₹8.69	₹7.64	₹2.09	₹4.97
	86.84×	—	—	—	—
	—	1.51×	1.76×	1.70×	1.30×
	—	270	110	222	274
	—	303	138	130	130

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

FORTIS₹754.90

Fortis Healthcare Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH MEDANTA AUROPHARMA LUPIN ALKEM LAURUSLABS MANKINDMcap ₹56,992 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	315.7	342.5	385.6	449.4	—
+ Impairment Loss / (Reversal)	-73.6	0.0	89.3	-32.9	—
+ Finance Costs	129.1	131.0	184.4	314.5	—
+ Interest Income	-23.8	0.0	-59.8	-39.4	—
+ Fair Value (Gains) / Losses	0.0	0.0	0.0	0.0	—
+ Unrealised FX (Gain) / Loss	-15.5	0.0	0.8	-0.2	—
+ Other Non-cash Items	14.8	0.0	51.8	30.7	—
+ Other — Cash Effects are Investing / Financing	0.0	0.0	-3.4	-2.6	—
+ Other Reconciling Items	-17.6	-16.0	0.0	0.0	—
Changes in Working Capital
+ Inventories	-2.0	13.9	-8.6	-15.7	—
+ Trade Receivables — Current	-123.3	-87.9	-219.9	-280.7	—
+ Other Financial Assets — Current	-10.5	0.0	-4.6	-13.2	—
+ Other Financial Assets — Non-current	-2.1	0.0	95.0	-96.6	—
+ Other Current Assets	9.3	-22.9	-6.7	-6.9	—
+ Other Non-current Assets	-24.3	0.0	-75.4	40.7	—
+ Other Bank Balances	0.0	0.0	0.3	0.0	—
+ Trade Payables — Current	104.2	51.9	104.4	113.5	—
+ Trade Payables — Non-current	0.0	0.0	0.0	36.4	—
+ Other Financial Liabilities — Current	17.4	0.0	-1,661.2	-37.7	—
+ Other Financial Liabilities — Non-current	-0.0	0.0	1,660.0	-11.6	—
+ Other Current Liabilities	11.4	64.6	4.1	21.7	—
+ Provisions — Current	-11.8	0.0	3.3	4.2	—
+ Provisions — Non-current	7.2	0.0	-1.4	48.5	—
Cash from Operating Activities
Profit Before Tax (per I/S)	791.8	848.5	995.5	1,349.5	1,360.7
+ Total Adjustments (incl. Working Capital)	304.6	477.1	538.1	521.9	—
Cash from Operations (pre-tax)	1,096.5	1,325.5	1,533.6	1,871.4	—
+ Interest Received — Operating	0.0	29.9	0.0	0.0	—
+ Other Inflows / (Outflows) — Operating	0.0	-33.5	0.0	0.4	—
+ Income Taxes Paid	274.2	221.8	109.7	269.9	—
Cash from Operating Activities	822.2	1,100.1	1,423.9	1,601.8	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	447.2	942.5	846.9	945.5	—
+ Disp of Fixed Assets	22.3	14.5	40.1	17.2	—
+ Acq of Investment Property	0.0	111.5	0.0	0.0	—
+ Disp of Investment Property	0.0	0.8	0.0	0.0	—
+ Acq of Other Long-term Assets	0.0	0.0	0.0	869.8	—
+ Disp of Other Long-term Assets	0.0	149.8	0.0	0.0	—
+ Purchase of Investments (Equity / Debt)	0.0	47.7	0.0	0.0	—
+ Acq of Subsidiaries / Businesses (net)	12.5	0.0	27.9	0.0	—
+ Loans & Advances Repaid	0.0	0.0	0.9	0.0	—
+ Dividends Received — Investing	2.8	4.9	0.0	5.5	—
+ Interest Received — Investing	25.6	29.8	59.7	39.5	—
+ Other Inflows / (Outflows) — Investing	35.4	15.6	-5.2	214.8	—
Cash from Investing Activities	-373.7	-886.4	-779.4	-1,538.4	—
Cash from Financing Activities
+ Payments — Change in Ownership of Subsidiaries	0.0	0.0	1,777.7	0.0	—
+ Proceeds from Debentures / Notes / Bonds	0.0	0.0	1,550.0	0.0	—
+ Proceeds from Borrowings	240.1	611.9	11.3	1,271.0	—
+ Repayment of Borrowings	521.9	426.4	198.5	667.7	—
+ Payment of Lease Liabilities	43.8	0.0	52.0	58.7	—
+ Payment of Finance Lease Liabilities	0.0	55.9	—	—	—
+ Interest Paid	129.7	130.0	138.1	303.1	—
+ Dividends Paid	16.0	86.0	108.9	77.7	—
Cash from Financing Activities	-471.2	-86.5	-713.8	163.8	—
Net Changes in Cash (pre-FX)	-22.7	127.3	-69.3	227.2	—
+ Effect of FX Rate Changes on Cash	1.2	-2.8	-0.5	1.3	—
Net Changes in Cash	-21.4	124.5	-69.8	228.4	—
Closing Cash	45.1	169.7	—	328.3	—
Reference Items
EBITDA	1,101.3	1,267.6	1,587.9	2,085.0	2,131.4
EBITDA Margin %	17.49	18.39	20.40	22.84	22.42
Free Cash Flow (CFO − Capex)	375.0	157.6	577.0	656.3	656.3
Free Cash Flow to Equity	—	-39.8	2,055.7	750.7	—
Free Cash Flow per Basic Share	4.97	2.09	7.64	8.69	8.69
Price to Free Cash Flow	—	—	—	—	86.84
Cash Flow to Net Income	1.30	1.70	1.76	1.51	—
Cash Paid for Taxes	274.2	221.8	109.7	269.9	—
Cash Paid for Interest	129.7	130.0	138.1	303.1	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.